Immunogenicity and protective efficacy in dogs of an MF59™-adjuvanted vaccine against recombinant canine/porcine coronavirus

Vaccine

Volumn 29, Issue 11, 2011, Pages 2018-2023

  Decaro, Nicola ^a   Mari, Viviana ^a   Sciarretta, Rossana ^a   Colao, Valeriana ^a   Losurdo, Michele ^a   Catella, Cristiana ^a   Elia, Gabriella ^a   Martella, Vito ^a   Del Giudice, Giuseppe ^b   Buonavoglia, Canio ^a  

^a UNIVERSITY OF BARI   (Italy)

^b NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

Author keywords

Inactivated vaccine; MF59 adjuvant; TGEV like canine coronavirus

Indexed keywords

INACTIVATED CORONAVIRUS VACCINE; INACTIVATED VACCINE; MIFAMURTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORONAVIRUS; DOG; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNITY; IMMUNOGENICITY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VIRUS INACTIVATION; VIRUS NEUTRALIZATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CORONAVIRUS INFECTIONS; CORONAVIRUS, CANINE; DOG DISEASES; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; NEUTRALIZATION TESTS; POLYSORBATES; SQUALENE; VACCINES, INACTIVATED; VIRAL VACCINES; VIRUS SHEDDING;

EID: 79951813373     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.01.028     Document Type: Article

References (30)

1. Carstens E.B. Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2009). Arch Virol 2010, 155:133-146.
2. Decaro N., Buonavoglia C. An update on canine coronaviruses: viral evolution and pathobiology. Vet Microbiol 2008, 132:221-234.
3. Evermann J.F., Abbott J.R., Han S. Canine coronavirus-associated puppy mortality without evidence of concurrent canine parvovirus infection. J Vet Diagn Invest 2005, 17:610-614.
4. Buonavoglia C., Decaro N., Martella V., Elia G., Campolo M., Desario C., et al. Canine coronavirus highly pathogenic for dogs. Emerg Infect Dis 2006, 12:492-494.
5. Decaro N., Martella V., Elia G., Campolo M., Desario C., Cirone F., et al. Molecular characterisation of the virulent canine coronavirus CB/05 strain. Virus Res 2007, 125:54-60.
6. Decaro N., Campolo M., Lorusso A., Desario C., Mari V., Colaianni M.L., et al. Experimental infection of dogs with a novel strain of canine coronavirus causing systemic disease and lymphopenia. Vet Microbiol 2008, 128:253-260.
7. Decaro N., Elia G., Martella V., Campolo M., Mari V., Desario C., et al. Immunity after natural exposure to enteric canine coronavirus does not provide complete protection against infection with the new pantropic CB/05 strain. Vaccine 2010, 28:724-729.
8. Marinaro M., Mari V., Bellacicco A.L., Tarsitano E., Elia G., Losurdo M., et al. Prolonged depletion of circulating CD4+ T lymphocytes and acute monocytosis after pantropic canine coronavirus infection in dogs. Virus Res 2010, 152:73-78.
9. Decaro N., Martella V., Ricci D., Elia G., Desario C., Campolo M., Cavaliere N., et al. Genotype-specific fluorogenic RT-PCR assays for the detection and quantitation of canine coronavirus type I and type II RNA in faecal samples of dogs. J Virol Methods 2005, 130:72-78.
10. Decaro N., Desario C., Billi M., Mari V., Elia G., Cavalli A., et al. Western European epidemiological survey for parvovirus and coronavirus infections in dogs. Vet J 2009, 10.1016/j.tvjl.2009.10.027.
11. Wang Y., Ma G., Lu C., Wen H. Detection of canine coronaviruses genotype I and II in raised Canidae animals in China. Berl Munch Tierarztl Wochenschr 2006, 119:35-39.
12. Soma T., Ohinata T., Ishii H., Takahashi T., Taharaguchi S., Hara M. Detection and genotyping of canine coronavirus RNA in diarrheic dogs in Japan. Res Vet Sci 2010, 10.1016/j.rvsc.2010.05.027.
13. Decaro N., Mari V., Campolo M., Lorusso A., Camero M., Elia G., et al. Recombinant canine coronaviruses related to transmissible gastroenteritis virus of swine are circulating in dogs. J Virol 2009, 83:1532-1537.
14. Erles K., Brownlie J. Sequence analysis of divergent canine coronavirus strains present in a UK dog population. Virus Res 2009, 141:21-25.
15. Decaro N., Mari V., Elia G., Addie D.D., Camero M., Lucente M.S., et al. Recombinant canine coronaviruses in dogs, Europe. Emerg Infect Dis 2010, 16:41-47.
16. Decaro N., Elia G., Martella V., Desario C., Campolo M., Di Trani L., et al. A real-time PCR assay for rapid detection and quantitation of canine parvovirus type 2 DNA in the feces of dogs. Vet Microbiol 2005, 105:19-28.
17. Elia G., Decaro N., Martella V., Cirone F., Lucente M.S., Lorusso E., et al. Detection of canine distemper virus in dogs by real-time RT-PCR. J Virol Methods 2006, 136:171-176.
18. Hu R.L., Huang G., Qiu W., Zhong Z.H., Xia X.Z., Yin Z. Detection and differentiation of CAV-1 and CAV-2 by polymerase chain reaction. Vet Res Commun 2001, 25:77-84.
19. Decaro N., Amorisco F., Desario C., Lorusso E., Camero M., Bellacicco A.L., et al. Development and validation of a real-time PCR assay for specific and sensitive detection of canid herpesvirus 1. J Virol Methods 2010, 169:176-180.
20. Gouvea V., Santos N., Timenetsky Mdo C. Identification of bovine and porcine rotavirus G types by PCR. J Clin Microbiol 1994, 32:1338-1340.
21. Decaro N., Campolo M., Desario C., Ricci D., Camero M., Lorusso E., et al. Virological and molecular characterization of a mammalian orthoreovirus type 3 strain isolated from a dog in Italy. Vet Microbiol 2005, 109:19-27.
22. Jiang X., Huang P.W., Zhong W.M., Farkas T., Cubitt D.W., Matson D.O. Design and evaluation of a primer pair that detects both Norwalk- and Sapporo-like caliciviruses by RT-PCR. J Virol Methods 1999, 83:145-154.
23. Decaro N., Pratelli A., Campolo M., Elia G., Martella V., Tempesta M., et al. Quantitation of canine coronavirus RNA in the faeces of dogs by TaqMan RT-PCR. J Virol Methods 2004, 119:145-150.
24. Pratelli A., Elia G., Martella V., Palmieri A., Cirone F., Tinelli A., et al. Prevalence of canine coronavirus antibodies by an enzyme-linked immunosorbent assay in dogs in the south of Italy. J Virol Methods 2002, 102:67-71.
25. Wesley R.D. The S gene of canine coronavirus, strain UCD-1, is more closely related to the S gene of transmissible gastroenteritis virus than to that of feline infectious peritonitis virus. Virus Res 1999, 61:145-152.
26. Pratelli A., Tinelli A., Decaro N., Cirone F., Elia G., Roperto S., et al. Efficacy of an inactivated canine coronavirus vaccine in pups. New Microbiol 2003, 26:151-155.
27. Pratelli A., Tinelli A., Decaro N., Martella V., Camero M., Tempesta M., et al. Safety and efficacy of a modified-live canine coronavirus vaccine in dogs. Vet Microbiol 2004, 99:43-49.
28. El Sahly H MF59™ as a vaccine adjuvant: a review of safety and immunogenicity. Expert Rev Vaccines 2010, 9:1135-1141.
29. Ott G., Barchfeld G.L., Chernoff D., Radhakrishnan R., van Hoogevest P., Van Nest G. MF59. Design and evaluation of a safe and potent adjuvant for human vaccines. Pharm Biotechnol 1995, 6:277-296.
30. Day M.J., Horzinek M.C., Schultz R.D. Guidelines for the vaccination of dogs and cats. Compiled by the Vaccination Guidelines Group (VGG) of the World Small Animal Veterinary Association (WSAVA). J Small Anim Pract 2007, 48:528-541. Vaccination Guidelines Group (VGG) of the World Small Animal Veterinary Association (WSAVA).